В статье продемонстрированы современные диагностические возможности эндокардиального электрофизиологического исследования у пациентов кардиологического профиля с брадисистолией и нарушениями проводимости, позволяющими адекватно оценить клиническую ситуацию. Нами была сделана попытка систематизировать текущие показания к проведению электрофизиологического исследования у этой категории пациентов на основании анализа нескольких текущих рекомендаций.

endocardial electrophysiological researchconduction disordersweakness of the sinus nodeatrioventricular blockdistal blockadetwo-beam blockadeэндокардиальное электрофизиологическое исследованиенарушения проводимостислабость синусового узлаатриовентрикулярная блокададистальная блокададвухпучковая блокада1.Scherlag BJ, Lau SH, Helfant RH, et al. Catheter technique for recording His bundle activity in man. Circulation. 1969;39(1):13–18. DOI: 10.1161/01.cir.39.1.13Scherlag B.J., Lau S.H., Helfant R.H., et al. Catheter technique for recording His bundle activity in man // Circulation. 1969. Vol. 39, No. 1. P. 13–18. DOI: 10.1161/01.cir.39.1.132.Durrer D, Schoo L, Schuilenburg RM, Wellens HJ. The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation. 1967;36(5):644–462. DOI: 10.1161/01.cir.36.5.644Durrer D., Schoo L., Schuilenburg R.M., Wellens H.J. The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome // Circulation. 1967. Vol. 36, No. 5. P. 644–462. DOI: 10.1161/01.cir.36.5.6443.Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000;342(26):1937–1945. DOI: 10.1056/NEJM200006293422602Buxton A.E., Lee K.L., DiCarlo L., et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators // N Engl J Med. 2000. Vol. 342, No. 26. P. 1937–1945. DOI: 10.1056/NEJM2000062934226024.Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–2867. DOI: 10.1093/eurheartj/ehv316Priori S.G., Blomström-Lundqvist C., Mazzanti A., et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) // Eur Heart J. 2015. Vol. 36, No. 41. P. 2793–2867. DOI: 10.1093/eurheartj/ehv3165.Muresan L, Cismaru G, Martins RP, et al. Recommendations for the use of electrophysiological study: Update 2018. Hell J Cardiol. 2019;60(2):82–100. DOI: 10.1016/j.hjc.2018.09.002Muresan L., Cismaru G., Martins R.P., et al. Recommendations for the use of electrophysiological study: Update 2018 // Hell J Cardiol. 2019. Vol. 60, No. 2. P. 82–100. DOI: 10.1016/j.hjc.2018.09.0026.Zaman S, Narayan A, Thiagalingam A, et al. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction. Circulation. 2014;129(8):848–854. DOI: 10.1161/CIRCULATIONAHA.113.005146Zaman S., Narayan A., Thiagalingam A., et al. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction // Circulation. 2014. Vol. 129, No. 8. Р. 848–854. DOI: 10.1161/CIRCULATIONAHA.113.0051467.Zaman S, Taylor AJ, Stiles M, et al. Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance. Heart, Lung and Circulation. 2016;25(11):1055–1062. DOI: 10.1016/j.hlc.2016.04.007Zaman S., Taylor A.J., Stiles M., et al. Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance // Heart, Lung and Circulation. 2016. Vol. 25, No. 11. Р. 1055–1062. DOI: 10.1016/j.hlc.2016.04.0078.Gatzoulis KA, Georgopoulos S, Antoniou CK, et al. Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. Int J Cardiol. 2018;254:175–181. DOI: 10.1016/j.ijcard.2017.10.033Gatzoulis K.A., Georgopoulos S., Antoniou C.K., et al. Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy // Int J Cardiol. 2018. Vol. 254. Р. 175–181. DOI: 10.1016/j.ijcard.2017.10.0339.Prystowsky EN, Klein GJ. Cardiac arrhythmias. An integrated approach for the clinician. McGraw-Hill, Inc., 1994. 452 p.Prystowsky E.N., Klein G.J. Cardiac arrhythmias. An integrated approach for the clinician. McGraw-Hill, Inc., 1994. 452 p.10.Fogoros RN. Electrophysiologic testing. 4th edition. Willey-Blackwell, 2006. 296 p. DOI: 10.1002/9780470750681Fogoros R.N. Electrophysiologic testing. 4th edition. Willey-Blackwell, 2006. 296 p. DOI: 10.1002/978047075068111.Brignole M, Alboni P, Benditt DG, et al. Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope--update 2004. Europace. 2004;6(6):467–537. DOI: 10.1016/j.eupc.2004.08.008Brignole M., Alboni P., Benditt D.G., et al. Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope--update 2004 // Europace. 2004. Vol. 6, No. 6. Р. 467–537. DOI: 10.1016/j.eupc.2004.08.00812.Benditt DG, Gornick CC, Dunbar D, et al. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation. 1987;(4 Pt 2):III93–102. PMID: 3549054Benditt D.G., Gornick C.C., Dunbar D., et al. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction // Circulation. 1987. No. 4, Pt. 2. P. III93–102. PMID: 354905413.Maisch B, Lotze U, Schneider J, Kochsiek K. Antibodies to human sinus node in sick sinus syndrome. Pacing Clin Electrophysiol. 1986;9(6):1101–1109. DOI: 10.1111/j.1540-8159.1986.tb06677.xMaisch B., Lotze U., Schneider J., Kochsiek K. Antibodies to human sinus node in sick sinus syndrome // Pacing Clin Electrophysiol. 1986. Vol. 9, No. 6. P. 1101–1109. DOI: 10.1111/j.1540-8159.1986.tb06677.x14.Fujimura O, Yee R, Klein GJ, et al. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. N Engl J Med. 1989;321(25):1703–1707. DOI: 10.1056/NEJM198912213212503Fujimura O., Yee R., Klein G.J., et al. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia // N Engl J Med. 1989. Vol. 321, No. 25. P. 1703–1707. DOI: 10.1056/NEJM19891221321250315.Kang PS, Gomes JA, El-Sherif N. Differential effects of functional autonomic blockade on the variables of sinus nodal automaticity in sick sinus syndrome. Am J Cardiol. 1982;49(2):273–282. DOI: 10.1016/0002-9149(82)90501-xKang P.S., Gomes J.A., El-Sherif N. Differential effects of functional autonomic blockade on the variables of sinus nodal automaticity in sick sinus syndrome // Am J Cardiol. 1982. Vol. 49, No. 2. P. 273–282. DOI: 10.1016/0002-9149(82)90501-x16.Bergfeldt L, Vallin H, Rosenqvist M, et al. Sinus node recovery time assessment revisited: role of pharmacologic blockade of the autonomic nervous system. J Cardiovasc Electrophysiol. 1996;7(2): 95–101. DOI: 10.1111/j.1540-8167.1996.tb00504.xBergfeldt L., Vallin H., Rosenqvist M., et al. Sinus node recovery time assessment revisited: role of pharmacologic blockade of the autonomic nervous system // J Cardiovasc Electrophysiol. 1996. Vol. 7, No. 2. P. 95–101. DOI: 10.1111/j.1540-8167.1996.tb00504.x17.Breithardt G, Seipel L, Loogen F. Sinus node recovery time and calculated sinoatrial conduction time in normal subjects and patients with sinus node dysfunction. Circulation. 1977;56(1):43–50. DOI: 10.1161/01.cir.56.1.43Breithardt G., Seipel L., Loogen F. Sinus node recovery time and calculated sinoatrial conduction time in normal subjects and patients with sinus node dysfunction // Circulation. 1977. Vol. 56, No. 1. P. 43–50. DOI: 10.1161/01.cir.56.1.4318.Strauss HC, Bigger JT, Saroff AL, Giardina EG. Electrophysiologic evaluation of sinus node function in patients with sinus node dysfunction. Circulation. 1976;53(5):763–776. DOI: 10.1161/01.cir.53.5.763Strauss H.C., Bigger J.T., Saroff A.L., Giardina E.G. Electrophysiologic evaluation of sinus node function in patients with sinus node dysfunction // Circulation. 1976. Vol. 53, No. 5. P. 763–776. DOI: 10.1161/01.cir.53.5.76319.Strauss HC, Saroff AL, Bigger JT Jr, Giardina EG. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man. Presentation of data and critical review of the literature. Circulation. 1973;47(1):86–93. DOI: 10.1161/01.cir.47.1.86Strauss H.C., Saroff A.L., Bigger J.T. Jr., Giardina E.G. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man. Presentation of data and critical review of the literature // Circulation. 1973. Vol. 47, No. 1. P. 86–93. DOI: 10.1161/01.cir.47.1.8620.Narula OS, Shantha N, Vasquez M, et al. A new method for measurement of sinoatrial conduction time. Circulation. 1978;58(4): 706–714. DOI: 10.1161/01.cir.58.4.706Narula O.S., Shantha N., Vasquez M., et al. A new method for measurement of sinoatrial conduction time // Circulation. 1978. Vol. 58, No. 4. P. 706–714. DOI: 10.1161/01.cir.58.4.70621.Zipes DP, Dimarco JP, Gillette PC, et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Clinical Intracardiac electrophysiologic and catheter ablation procedures), developed in collaboration with the North American Society of pacing and electrophysiology. J Am Coll Cardiol. 1995;26(2):555–573. DOI: 10.1016/0735-1097(95)80037-hZipes D.P., Dimarco J.P., Gillette P.C., et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Clinical Intracardiac electrophysiologic and catheter ablation procedures), developed in collaboration with the North American Society of pacing and electrophysiology // J Am Coll Cardiol. 1995. Vol. 26, No. 2. P. 555–573. DOI: 10.1016/0735-1097(95)80037-h22.Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281–2329. DOI: 10.1093/eurheartj/ehab364Brignole M., Auricchio A., Baron-Esquivias G., et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) // Eur Heart J. 2013. Vol. 34, No. 29. P. 2281–2329. DOI: 10.1093/eurheartj/ehab36423.Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012;125(21):2566–2571. DOI: 10.1161/CIRCULATIONAHA.111.082313Brignole M., Menozzi C., Moya A., et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial // Circulation. 2012. Vol. 125, No. 21. P. 2566–2571. DOI: 10.1161/CIRCULATIONAHA.111.08231324.Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–e75. DOI: 10.1016/j.jacc.2012.11.007Tracy C.M., Epstein A.E., Darbar D., et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society // J Am Coll Cardiol. 2013. Vol. 61, No. 3. P. e6–e75. DOI: 10.1016/j.jacc.2012.11.00725.Aste M, Brignole M. Syncope and paroxysmal atrioventricular block. J Arrhythm. 2017;33(6):562–567. DOI: 10.1016/j.joa.2017.03.008Aste M., Brignole M. Syncope and paroxysmal atrioventricular block // J Arrhythm. 2017. Vol. 33, No. 6. P. 562–567. DOI: 10.1016/j.joa.2017.03.00826.Scheinman MM, Peters RW, Suave MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 1982;50(6):1316–1322. DOI: 10.1016/0002-9149(82)90469-6Scheinman M.M., Peters R.W., Suave M.J., et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing // Am J Cardiol. 1982. Vol. 50, No. 6. P. 1316–1322. DOI: 10.1016/0002-9149(82)90469-627.Gronda M, Magnani A, Occhetta E, et al. Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications. Giornale italiano di cardiologia. 1984;14(10):768–773.Gronda M., Magnani A., Occhetta E., et al. Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications // Giornale italiano di cardiologia. 1984. Vol. 14, No. 10. P. 768–773.28.Bergfeldt L, Edvardsson N, Rosenqvist M, et al. Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemaker. Am J Cardiol. 1994;74(11):1129–1132. DOI: 10.1016/0002-9149(94)90465-0Bergfeldt L., Edvardsson N., Rosenqvist M., et al. Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemaker // Am J Cardiol. 1994. Vol. 74, No. 11. P. 1129–1132. DOI: 10.1016/0002-9149(94)90465-029.Kaul U, Dev V, Narula J, et al. Evaluation of patients with bundle branch block and “unexplained” syncope: a study based on comprehensive electrophysiologic testing and ajmaline stress. PACE. 1988;11(3):289–297. DOI: 10.1111/j.1540-8159.1988.tb05006.xKaul U., Dev V., Narula J., et al. Evaluation of patients with bundle branch block and “unexplained” syncope: a study based on comprehensive electrophysiologic testing and ajmaline stress // PACE. 1988. Vol. 11, No. 3. P. 289–297. DOI: 10.1111/j.1540-8159.1988.tb05006.x30.Twidale N, Tonkin AM. Procainamide administration during electrophysiology study--utility as a provocative test for intermittent atrioventricular block. PACE. 1988;11(1):124. DOI: 10.1111/j.1540-8159.1988.tb03939.xTwidale N., Tonkin A.M. Procainamide administration during electrophysiology study--utility as a provocative test for intermittent atrioventricular block // PACE. 1988. Vol. 11, No. 1. P. 124. DOI: 10.1111/j.1540-8159.1988.tb03939.x31.Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–e75. DOI: 10.1016/j.jacc.2012.11.007Tracy C.M., Epstein A.E., Darbar D., et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society // J Am Coll Cardiol. 2013. Vol. 61, No. 3. P. e6–e75. DOI: 10.1016/j.jacc.2012.11.00732.Englund A, Bergfeldt L, Rehnqvist N, et al. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol. 1995;26(6):1508–1515. DOI: 10.1016/0735-1097(95)00354-1Englund A., Bergfeldt L., Rehnqvist N., et al. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope // J Am Coll Cardiol. 1995. Vol. 26, No. 6. P. 1508–1515. DOI: 10.1016/0735-1097(95)00354-133.Click RL, Gersh BJ, Sugrue DD, et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol. 1987;59(8):817–823. DOI: 10.1016/0002-9149(87)91098-8Click R.L., Gersh B.J., Sugrue D.D., et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block // Am J Cardiol. 1987. Vol. 59, No. 8. P. 817–823. DOI: 10.1016/0002-9149(87)91098-834.Morady F, Higgins J, Peters RW, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol. 1984;54(6):587–591. DOI: 10.1016/0002-9149(84)90254-6Morady F., Higgins J., Peters R.W., et al. Electrophysiologic testing in bundle branch block and unexplained syncope // Am J Cardiol. 1984. Vol. 54, No. 6. P. 587–591. DOI: 10.1016/0002-9149(84)90254-635.Moya A, Garcia-Civera R, Croci F, et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011;32(12):1535–1541. DOI: 10.1093/eurheartj/ehr071Moya A., Garcia-Civera R., Croci F., et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block // Eur Heart J. 2011. Vol. 32, No. 12. P. 1535–1541. DOI: 10.1093/eurheartj/ehr07136.Guerot C, Coste A, Valere PE, Tricot R. Ajmaline test in the diagnosis of paroxysmal atrioventricular block. Archives des maladies du coeur et des vaisseaux. 1973;66(10):1241–1253. (In French)Guerot C., Coste A., Valere P.E., Tricot R. L’epreuve a l’Ajmaline dans le diagnostic du bloc auriculo-ventriculaire paroxystique // Archives des maladies du coeur et des vaisseaux. 1973. Vol. 66, No. 10. P. 1241–1253.37.Di Matteo J, Vacheron A, Guize L, et al. Value of recording the bundle of His potential with pharmacodynamic tests in heart conduction disorders. Annales de medecine interne. 1974;125(4): 371–376. (In French).Di Matteo J., Vacheron A., Guize L., et al. Interet de l’enregistrement du potentiel hisien avec epreuves pharmacodynamiques dans les troubles de la conduction cardiaque // Annales de medecine interne. 1974. Vol. 125, No. 4. P. 371–376.38.Englund A, Bergfeldt L, Rosenqvist M. Pharmacological stress testing of the His-Purkinje system in patients with bifascicular block. PACE. 1998;21(10):1979–1987. DOI: 10.1111/j.1540-8159.1998.tb00017.xEnglund A., Bergfeldt L., Rosenqvist M. Pharmacological stress testing of the His-Purkinje system in patients with bifascicular block // PACE. 1998. Vol. 21, No. 10. P. 1979–1987. DOI: 10.1111/j.1540-8159.1998.tb00017.x39.Brembilla-Perrot B. Pharmacological testing in the diagnosis of arrhythmias. Minerva cardioangiologica. 2010;58(4):505–517.Brembilla-Perrot B. Pharmacological testing in the diagnosis of arrhythmias // Minerva cardioangiologica. 2010. Vol. 58, No. 4. P. 505–517.40.Pentimalli F, Bacino L, Ghione M, et al. Ajmaline Challenge To Unmask Infrahisian Disease In Patients With Recurrent And Unexplained Syncope, Preserved Ejection Fraction, With Or Without Conduction Abnormalities On Surface ECG. Journal of atrial fibrillation. 2016;9(2):1421. DOI: 10.4022/jafib.1421Pentimalli F., Bacino L., Ghione M., et al. Ajmaline Challenge To Unmask Infrahisian Disease In Patients With Recurrent And Unexplained Syncope, Preserved Ejection Fraction, With Or Without Conduction Abnormalities On Surface ECG // Journal of atrial fibrillation. 2016. Vol. 9, No. 2. P. 1421. DOI: 10.4022/jafib.142141.Gaede L, Kim W-K, Liebetrau C, et al. Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol. 2018;107(1):60–69. DOI: 10.1007/s00392-017-1158-2Gaede L., Kim W.-K., Liebetrau C., et al. Pacemaker implantation after TAVI: predictors of AV block persistence // Clin Res Cardiol. 2018. Vol. 107, No. 1. P. 60–69. DOI: 10.1007/s00392-017-1158-242.Kostopoulou A, Karyofillis P, Livanis E, et al. Permanent pacing after transcatheter aortic valve implantation of a CoreValve prosthesis as determined by electrocardiographic and electrophysiological predictors: a single-centre experience. EP Europace. 2016;18(1): 131–137. DOI: 10.1093/europace/euv137Kostopoulou A., Karyofillis P., Livanis E., et al. Permanent pacing after transcatheter aortic valve implantation of a CoreValve prosthesis as determined by electrocardiographic and electrophysiological predictors: a single-centre experience // EP Europace. 2016. Vol. 18, No. 1. P. 131–137. DOI: 10.1093/europace/euv137